Markets:

Overview

News

Currencies

International

Treasuries

Certara, Inc. - Common Stock (NQ:CERT)

8.260 +0.260 (+3.25%)

Streaming Delayed Price Updated: 12:12 PM EDT, Sep 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Certara, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Certara (CERT) Q2 2026 Earnings Call Transcript ↗

August 04, 2026

Software revenue hit 53% of total as AI-assisted code boosted development 65% year over year.

Via The Motley Fool

Topics Artificial Intelligence Earnings

Certara Q2 Earnings Call Highlights ↗

August 04, 2026

Certara (NASDAQ:CERT) reported second-quarter 2026 revenue of $93.3 million, up 1% year over year, as software growth offset a decline in services revenue. Management reaffirmed its full-year revenue...

Via MarketBeat

Topics Artificial Intelligence Earnings

Transcript: Certara Q2 2026 Earnings Conference Call ↗

August 04, 2026

Certara (NASDAQ:CERT) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga...

Via Benzinga

Topics Earnings

Certara (NASDAQ:CERT) Q1 2026: Software Shines, but Divestiture and Mixed Metrics Weigh on Shares ↗

May 11, 2026

Via Chartmill

Certara Inc (NASDAQ:CERT) Reports Mixed Q4 2025 Results and Cautious 2026 Outlook ↗

February 26, 2026

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Earnings Scheduled For May 5, 2025 ↗

May 05, 2025

Via Benzinga

Tuesday's pre-market session: top gainers and losers ↗

August 04, 2026

Via Chartmill

Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference ↗

June 07, 2026

Certara (NASDAQ:CERT) executives outlined the company’s strategic realignment, artificial intelligence initiatives and cost priorities during a discussion at Jefferies’ 2026 Global Healthcare...

Via MarketBeat

Topics Artificial Intelligence

Certara (CERT) Q1 2026 Earnings Call Transcript ↗

May 11, 2026

Certara (CERT) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Artificial Intelligence Earnings

Certara Q1 Earnings Call Highlights ↗

May 11, 2026

Certara (NASDAQ:CERT) reported first-quarter 2026 revenue of $106.9 million, up 1% from the prior-year period, as stronger software performance offset softer services results and the company outlined a...

Via MarketBeat

Topics Earnings

Certara’s Volatility: From a 23% Earnings Plunge to a $3 Million Institutional Vote of Confidence

January 05, 2026

The biosimulation market was sent into a tailspin in the closing months of 2025 as Certara (Nasdaq:CERT), a global leader in model-informed drug development, saw its market valuation crater by 23%. The...

Via MarketMinute

Topics Earnings

Certara Stock Fell 23% After Earnings and This Fund Bought Up $3 Million Anyway ↗

January 05, 2026

Certara provides biosimulation software and regulatory solutions to global biopharma clients, supporting drug development and approvals.

Via The Motley Fool

ArrowMark Slashes Alight Position Amid Growing Questions About Its Recurring-Revenue Strategy ↗

December 04, 2025

ArrowMark’s sharp reduction in its Alight stake comes at a moment when the market is questioning whether the company can turn its consulting-heavy work into steadier recurring revenue, and that tension...

Via The Motley Fool

Topics Regulatory Compliance

The Next Wave Of AI Winners? Investors Shift Focus Beyond Nvidia ↗

November 17, 2025

Goldman Sachs says investors are shifting toward companies quietly using AI to cut costs and drive productivity-led growth.

Via Benzinga

Topics Artificial Intelligence

Beyond The Numbers: 4 Analysts Discuss Certara Stock ↗

October 02, 2025

Via Benzinga

RH Posts Downbeat Results, Joins Frequency Electronics, Tronox And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

September 12, 2025

Via Benzinga

Certara (CERT) Q2 Revenue Jumps 12% ↗

August 06, 2025

Via The Motley Fool

Topics Artificial Intelligence

What Analysts Are Saying About Certara Stock ↗

July 03, 2025

Via Benzinga

10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential ↗

June 28, 2025

Via The Motley Fool

Topics Artificial Intelligence

3 Momentum Stocks That Could Soar Post-Market Volatility

April 21, 2025

Three unexpected companies have rallied quickly in the period following tariff-related market turbulence; can they maintain momentum?

Via MarketBeat

Topics Artificial Intelligence World Trade

Hertz Global And Webull Stocks Are Among Top Mid-Cap Gainers Last Week (Apr 14-Apr 18): Are The Others In Your Portfolio? ↗

April 20, 2025

Top mid-cap performers last week: Webull Corp, Hertz Global, Metsera Inc, Vista Energy, Certara Inc, Sibanye-Stillwater, Banco Macro, Grupo Financiero Galicia, Banco BBVA Argentina, Recursion...

Via Benzinga

Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News ↗

April 15, 2025

Via Stocktwits

Topics Animal Testing Artificial Intelligence Stocks

Top 3 Health Care Stocks You May Want To Dump This Quarter ↗

April 15, 2025

Via Benzinga

Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report ↗

April 14, 2025

Certara reports $106M Q1 revenue, authorizes $100M buyback, and launches a new AI-driven non-animal testing tool to support biopharma innovation.

Via Benzinga

These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio? ↗

April 13, 2025

Top mid-cap stock performers last week: AGL, RXRX, CERT, AVAV, STRL, ORLA, IAG, SBSW, LOAR, RYTM, TLX. High gains due to positive news and macro uncertainty.

Via Benzinga

What Analysts Are Saying About Certara Stock ↗

April 11, 2025

Via Benzinga

What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday? ↗

April 11, 2025

FDA introduces a new roadmap to reduce animal testing in monoclonal antibody development using AI models, organoid testing and real-world data to enhance safety and efficiency.

Via Benzinga

Topics Animal Testing Artificial Intelligence

Top movers in Friday's pre-market session ↗

April 11, 2025

As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.